Puma Biotechnology, Inc. (PBYI) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Puma Biotechnology, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | 9.56x | 4.90x | 9.45x | 94486.57x | -4.24x | -6.77x |
| P/B Ratio | 2.28x | 1.61x | 3.82x | 8.75x | -50.51x | -68.23x |
| P/S Ratio | 1.30x | 0.64x | 0.87x | 0.83x | 0.49x | 1.80x |
| Profitability | ||||||
| Gross Margin | 74.5% | 72.1% | 73.4% | 75.8% | 74.8% | 82.5% |
| Operating Margin | 16.3% | 13.4% | 13.9% | 10.4% | 0.5% | -13.5% |
| Net Margin | 13.6% | 13.1% | 9.2% | 0.0% | -11.5% | -26.7% |
| EBITDA Margin | 23.4% | 20.9% | 20.2% | 9.6% | -1.9% | -15.9% |
| Liquidity | ||||||
| Current Ratio | 2.00x | 1.54x | 1.57x | 1.73x | 1.28x | 1.28x |
| Quick Ratio | 1.93x | 1.45x | 1.50x | 1.67x | 1.21x | 1.25x |
| Leverage | ||||||
| Debt/Equity | 0.22x | 0.80x | 2.09x | 5.29x | -47.69x | -20.32x |
YoY = year-over-year change. Source: FMP..